data_1xq8_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1xq8 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.417 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.21 -0.663 . . . . 5.9500000000000002 109.21 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.423 ' C ' ' N ' ' A' ' 4' ' ' PHE . 1.2 m-20 -61.27 105.64 0.52 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.017 -1.052 . . . . 2.7599999999999998 108.9 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 58.6 t -51.25 -14.57 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.428 -0.795 . . . . 1.8999999999999999 109.558 -178.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.423 ' N ' ' C ' ' A' ' 2' ' ' ASP . 90.3 m-85 -77.64 -47.54 19.02 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.203 -0.936 . . . . 3.46 109.391 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 15.6 mmt -51.64 -49.54 62.06 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.252 -0.905 . . . . 2.4900000000000002 109.228 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -53.07 -57.17 11.33 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.323 -0.86 . . . . 3.1899999999999999 109.503 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -53.22 -31.16 41.15 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.529 -1.429 . . . . 0.89000000000000001 109.529 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.0 tp -74.65 -51.46 14.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.22 -1.165 . . . . 2.5699999999999998 109.474 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.8 t -63.57 -22.08 66.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.249 -0.907 . . . . 1.8999999999999999 109.51 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -75.18 -40.08 59.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.212 -0.93 . . . . 3.5899999999999999 109.448 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.72 -46.16 76.4 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.188 -0.945 . . . . 1.3500000000000001 109.462 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -54.67 -32.49 59.32 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.187 -0.946 . . . . 3.5499999999999998 109.482 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -65.56 -32.94 74.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.269 -0.894 . . . . 2.4900000000000002 109.451 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -79.11 -43.34 10.86 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.525 -1.43 . . . . 0.84999999999999998 109.525 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.1 t -57.79 -38.66 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.348 -1.09 . . . . 2.0899999999999999 109.419 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 74.6 t -71.9 -47.81 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.268 -0.895 . . . . 1.6799999999999999 109.338 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.99 -39.76 79.0 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.268 -0.895 . . . . 1.3100000000000001 109.398 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.1 -33.6 74.83 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.226 -0.921 . . . . 1.3899999999999999 109.36 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.77 -54.49 38.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.279 -0.888 . . . . 1.3 109.478 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -51.41 -41.91 61.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.23 -0.919 . . . . 2.1400000000000001 109.44 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -70.94 -55.97 7.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.193 -0.942 . . . . 3.0600000000000001 109.511 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.9 m -56.5 -33.26 65.84 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.08 -1.013 . . . . 1.97 109.427 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -72.78 -28.84 62.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.175 -0.953 . . . . 3.3100000000000001 109.389 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -82.66 -24.13 33.88 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.306 -0.871 . . . . 3.0 109.45 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -71.53 -49.86 23.04 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.534 -1.427 . . . . 0.89000000000000001 109.534 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.5 m -60.36 -33.27 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.264 -1.139 . . . . 1.45 109.421 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.43 -53.84 53.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.31 -0.869 . . . . 1.26 109.517 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -67.23 -37.08 82.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.337 -0.852 . . . . 2.23 109.453 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.61 -43.31 93.81 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.207 -0.933 . . . . 1.5600000000000001 109.482 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -53.75 -59.49 4.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.211 -0.93 . . . . 1.4099999999999999 109.443 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.69 -27.5 64.06 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.69 -1.364 . . . . 0.93999999999999995 109.69 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -70.65 -45.19 65.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.164 -1.198 . . . . 3.6000000000000001 109.281 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.9 m -65.14 -23.41 67.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.216 -0.928 . . . . 2.1800000000000002 109.082 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -63.72 -37.16 86.31 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.502 -0.749 . . . . 3.79 109.421 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -81.28 -20.37 41.02 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.21 -0.931 . . . . 3.0299999999999998 109.57 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -57.26 -57.05 21.8 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.714 -1.354 . . . . 1.1899999999999999 109.714 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.3 m -57.13 -30.71 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.191 -1.182 . . . . 2.6600000000000001 109.602 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 12.0 tp -85.94 119.49 26.31 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.173 -0.955 . . . . 2.8999999999999999 109.39 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -67.07 160.93 25.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.198 -0.939 . . . . 5.0499999999999998 108.958 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.53 ' C ' ' H ' ' A' ' 42' ' ' SER . 5.3 t -145.82 89.27 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.404 -0.81 . . . . 2.46 108.958 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -48.63 -9.93 0.1 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 110.141 -1.184 . . . . 0.91000000000000003 110.141 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.53 ' H ' ' C ' ' A' ' 40' ' ' VAL . 5.5 t -80.63 -46.89 14.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.036 -1.273 . . . . 2.1299999999999999 109.621 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? -85.71 83.71 7.78 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.152 -0.967 . . . . 3.7200000000000002 109.536 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.402 ' CG2' ' N ' ' A' ' 45' ' ' LYS . 92.8 m -91.31 165.76 13.26 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.312 -0.868 . . . . 1.4099999999999999 109.413 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.402 ' N ' ' CG2' ' A' ' 44' ' ' THR . 62.8 mttm -50.18 -56.57 10.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.313 -0.867 . . . . 3.29 109.5 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -50.28 -33.65 20.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.241 -0.912 . . . . 2.71 109.546 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.57 -38.74 86.66 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.422 -1.471 . . . . 0.65000000000000002 109.422 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 74.8 t -65.66 -46.11 90.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -1.148 . . . . 1.9099999999999999 109.372 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 69.1 t -55.94 -39.31 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.2 -0.938 . . . . 1.45 109.407 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 42.4 t60 -70.21 -27.35 64.41 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.214 -0.929 . . . . 2.1400000000000001 109.433 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -67.92 -60.76 5.41 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.503 -1.439 . . . . 0.56999999999999995 109.503 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.0 m -56.11 -30.22 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.36 -1.082 . . . . 1.24 109.329 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.23 -35.32 77.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.207 -0.933 . . . . 1.1599999999999999 109.463 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.2 m -75.7 -41.4 53.76 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.228 -0.92 . . . . 1.8700000000000001 109.455 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 75.8 t -63.3 -22.32 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.219 -0.926 . . . . 1.26 109.506 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.02 -24.22 61.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.159 -0.963 . . . . 1.1599999999999999 109.523 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -77.21 -40.5 44.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.158 -0.964 . . . . 2.6099999999999999 109.382 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -70.17 -39.58 75.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.199 -0.938 . . . . 3.8300000000000001 109.327 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.8 m -50.0 -27.38 5.37 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.296 -0.878 . . . . 1.8799999999999999 109.486 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -72.44 -40.02 67.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.38 -0.825 . . . . 2.5600000000000001 109.494 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -70.71 -22.64 62.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.278 -0.889 . . . . 2.1899999999999999 109.558 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -79.79 -61.15 2.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.209 -0.932 . . . . 3.2599999999999998 109.516 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.513 ' O ' ' N ' ' A' ' 67' ' ' GLY . 30.2 m -51.02 -32.44 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.19 -0.944 . . . . 1.5 109.542 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.426 ' H ' ' HG1' ' A' ' 64' ' ' THR . 10.0 p -66.01 -47.32 74.85 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.178 -0.951 . . . . 2.0099999999999998 109.472 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -66.32 -46.36 77.14 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.155 -0.966 . . . . 3.0 109.551 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 51.2 t -75.89 -28.02 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.176 -0.952 . . . . 2.0600000000000001 109.465 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 63' ' ' VAL . . . -49.11 -36.54 21.55 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.58 -1.408 . . . . 0.77000000000000002 109.58 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.93 -16.16 77.57 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.52 -1.432 . . . . 1.01 109.52 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.77 -48.4 11.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.206 -1.173 . . . . 1.54 109.579 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.9 m -58.59 -35.58 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.207 -0.933 . . . . 2.1499999999999999 109.546 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 70.2 t -65.5 -45.16 93.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.166 -0.959 . . . . 1.5 109.165 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.1 p -66.42 -39.51 89.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.283 -0.886 . . . . 2.1299999999999999 109.325 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -61.02 -54.36 37.45 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.49 -1.444 . . . . 0.98999999999999999 109.49 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 79.8 t -51.4 -38.41 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.278 -1.13 . . . . 1.4199999999999999 109.343 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 17.4 m -59.3 -41.18 88.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.276 -0.89 . . . . 2.27 109.303 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.34 -41.04 96.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.204 -0.935 . . . . 1.3600000000000001 109.343 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 43.2 t -68.43 -31.97 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.219 -0.926 . . . . 1.51 109.351 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.66 -50.54 73.07 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.266 -0.896 . . . . 1.3400000000000001 109.532 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -71.16 -17.41 62.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.254 -0.904 . . . . 2.6499999999999999 109.324 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 55.0 tttm -81.8 -21.44 37.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.886 . . . . 3.3799999999999999 109.145 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.3 m -81.18 -51.66 8.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.34 -0.85 . . . . 1.97 109.602 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.5 m -52.68 -38.47 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.213 -0.929 . . . . 1.3700000000000001 109.511 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -63.16 -44.49 95.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.192 -0.943 . . . . 2.4300000000000002 109.299 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -56.74 -25.43 51.64 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.389 -1.484 . . . . 0.98999999999999999 109.389 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -57.49 -35.34 70.08 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.303 -1.116 . . . . 1.45 109.32 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -51.71 -43.71 54.04 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.417 -1.473 . . . . 0.96999999999999997 109.417 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 38.3 t -59.9 -41.58 91.96 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.305 -1.115 . . . . 1.8700000000000001 109.378 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 60.9 mt -61.11 -42.42 93.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.265 -0.897 . . . . 2.4700000000000002 109.358 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.48 -41.11 65.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.218 -0.926 . . . . 1.6699999999999999 109.321 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.03 -46.39 81.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.289 -0.882 . . . . 1.8799999999999999 109.351 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -54.28 -42.56 70.15 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.162 -0.961 . . . . 1.9299999999999999 109.39 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.9 m -77.56 -47.93 18.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.277 -0.889 . . . . 2.71 109.392 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -79.65 93.68 1.38 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.508 -1.437 . . . . 2.4399999999999999 109.508 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -59.88 146.07 43.45 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.196 -1.179 . . . . 4.79 109.297 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.6 m -52.18 101.52 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.139 -0.976 . . . . 4.3300000000000001 109.23 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 48.9 tttp -46.73 163.31 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.239 -0.913 . . . . 5.4500000000000002 109.598 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.472 ' CB ' ' HZ1' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -155.5 102.45 2.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.168 -0.957 . . . . 6.79 109.565 -179.728 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -95.14 113.87 25.61 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.171 -0.956 . . . . 5.96 109.999 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -175.72 -30.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.233 -0.917 . . . . 7.9100000000000001 109.455 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 83.4 mt -112.14 158.32 19.78 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.633 -0.667 . . . . 7.8300000000000001 109.744 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -130.21 -2.62 5.01 Favored Glycine 0 N--CA 1.497 2.753 0 N-CA-C 109.038 -1.625 . . . . 6.5899999999999999 109.038 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 58.6 tttm 48.1 90.03 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.415 -1.05 . . . . 10.1 109.581 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -144.6 74.11 1.4 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.178 -0.951 . . . . 8.7899999999999991 109.233 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.497 ' H ' ' CD ' ' A' ' 104' ' ' GLU . 1.0 OUTLIER -65.37 -42.05 93.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.038 -1.039 . . . . 10.619999999999999 109.503 -179.597 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.415 ' C ' ' H ' ' A' ' 107' ' ' ALA . 1.4 mt-10 168.47 120.48 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 108.537 -0.912 . . . . 10.890000000000001 108.537 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -78.82 38.34 1.94 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.222 -1.551 . . . . 10.73 109.222 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.415 ' H ' ' C ' ' A' ' 105' ' ' GLU . . . 51.67 55.78 15.79 Favored Pre-proline 0 C--N 1.304 -1.388 0 O-C-N 121.506 -0.997 . . . . 11.24 109.772 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.46 ' O ' ' O ' ' A' ' 109' ' ' GLN . 93.4 Cg_endo -79.03 59.65 7.47 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.794 2.329 . . . . 10.75 111.885 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.46 ' O ' ' O ' ' A' ' 108' ' ' PRO . 78.6 mt-30 -57.01 -109.53 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.02 -1.05 . . . . 12.390000000000001 109.691 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -171.13 -17.46 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.139 -0.976 . . . . 10.800000000000001 109.374 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -168.29 -177.07 39.17 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.674 -1.37 . . . . 10.91 109.674 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.493 ' H ' ' CD1' ' A' ' 112' ' ' ILE . 0.0 OUTLIER -78.23 -37.67 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.205 -1.174 . . . . 11.050000000000001 109.548 179.898 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.547 ' C ' ' H ' ' A' ' 115' ' ' ASP . 85.3 mt -69.0 157.59 36.48 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.343 -0.848 . . . . 11.539999999999999 109.358 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -54.43 -3.87 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.183 -0.948 . . . . 12.140000000000001 109.657 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.547 ' H ' ' C ' ' A' ' 113' ' ' LEU . 28.3 t70 60.42 34.96 20.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.291 -0.881 . . . . 10.210000000000001 109.664 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.619 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 25.5 ttm -132.5 37.81 0.4 Allowed Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.588 -0.695 . . . . 10.91 110.384 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 116' ' ' MET . 62.1 Cg_endo -71.2 -12.18 29.77 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 122.131 1.887 . . . . 9.0800000000000001 111.013 178.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.6 p -54.81 134.23 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.655 -0.653 . . . . 10.9 109.973 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -97.84 126.84 39.24 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.424 -0.797 . . . . 9.6699999999999999 108.972 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -74.67 -11.59 22.15 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.707 1.605 . . . . 9.9000000000000004 112.035 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 122' ' ' ASN . 40.5 p-10 -63.84 -36.92 85.51 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.287 -0.883 . . . . 10.1 110.023 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.568 HD21 ' N ' ' A' ' 122' ' ' ASN . 0.0 OUTLIER -170.31 30.68 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.193 -0.942 . . . . 11.380000000000001 109.814 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 66.99 -52.52 0.47 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.384 -0.823 . . . . 11.51 109.699 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.511 ' O ' ' ND2' ' A' ' 122' ' ' ASN . . . -156.57 -139.7 0.08 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.205 -0.934 . . . . 12.17 109.157 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -53.41 -72.31 0.06 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.005 -1.06 . . . . 12.869999999999999 108.971 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -151.08 88.83 1.48 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.381 -0.825 . . . . 13.68 109.214 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' MET . . . . . 0.447 ' CB ' ' CD ' ' A' ' 128' ' ' PRO . 0.9 OUTLIER 52.67 -171.21 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.689 0 N-CA-C 107.847 -1.168 . . . . 15.460000000000001 107.847 179.571 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.447 ' CD ' ' CB ' ' A' ' 127' ' ' MET . 51.3 Cg_exo -53.69 161.4 4.46 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 121.662 1.575 . . . . 14.6 112.014 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.443 ' O ' ' C ' ' A' ' 130' ' ' GLU . 78.1 p -57.75 -42.36 83.77 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.294 -0.879 . . . . 14.869999999999999 110.598 -178.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 129' ' ' SER . 20.5 pt-20 35.41 -149.52 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.601 -0.687 . . . . 15.640000000000001 110.617 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -134.6 44.27 2.68 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.196 -0.94 . . . . 16.059999999999999 109.159 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.568 ' O ' ' N ' ' A' ' 134' ' ' GLN . . . 73.38 -56.24 1.98 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.216 -1.553 . . . . 15.289999999999999 109.216 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 8.5 t80 56.83 -77.99 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.634 -0.921 . . . . 17.390000000000001 109.25 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.568 ' N ' ' O ' ' A' ' 132' ' ' GLY . 8.9 pt20 -155.17 126.39 7.21 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.008 -1.057 . . . . 16.02 109.437 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -163.33 -17.92 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.751 -0.833 . . . . 16.16 108.751 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -132.37 124.03 27.93 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.674 0.75 . . . . 17.219999999999999 109.177 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.419 ' CB ' ' CD ' ' A' ' 138' ' ' PRO . 1.8 mm-40 -57.9 -62.87 4.61 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.361 -0.837 . . . . 15.789999999999999 110.581 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.419 ' CD ' ' CB ' ' A' ' 137' ' ' GLU . 20.6 Cg_endo -58.84 167.92 4.89 Favored 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 122.32 2.013 . . . . 16.07 112.066 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.476 ' OE1' ' N ' ' A' ' 139' ' ' GLU . 57.6 mp0 -55.92 -27.05 50.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.385 -0.822 . . . . 16.68 109.677 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.839 0 CA-C-O 117.818 -1.087 . . . . 17.609999999999999 109.354 179.988 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.411 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.21 -0.663 . . . . 5.59 109.21 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.423 ' C ' ' N ' ' A' ' 4' ' ' PHE . 1.2 m-20 -61.27 105.64 0.52 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.017 -1.052 . . . . 2.76 108.9 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 58.6 t -51.25 -14.57 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.428 -0.795 . . . . 1.36 109.558 -178.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.423 ' N ' ' C ' ' A' ' 2' ' ' ASP . 90.3 m-85 -77.64 -47.54 19.02 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.203 -0.936 . . . . 2.77 109.391 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 15.6 mmt -51.64 -49.54 62.06 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.252 -0.905 . . . . 1.89 109.228 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -53.07 -57.17 11.33 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.323 -0.86 . . . . 2.74 109.503 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -53.22 -31.16 41.15 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.529 -1.429 . . . . 0.86 109.529 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.0 tp -74.65 -51.46 14.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.22 -1.165 . . . . 2.04 109.474 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.8 t -63.57 -22.08 66.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.249 -0.907 . . . . 1.48 109.51 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -75.18 -40.08 59.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.212 -0.93 . . . . 3.12 109.448 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.72 -46.16 76.4 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.188 -0.945 . . . . 0.87 109.462 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -54.67 -32.49 59.32 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.187 -0.946 . . . . 3.02 109.482 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -65.56 -32.94 74.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.269 -0.894 . . . . 2.49 109.451 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -79.11 -43.34 10.86 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.525 -1.43 . . . . 0.81 109.525 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.1 t -57.79 -38.66 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.348 -1.09 . . . . 1.48 109.419 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 74.6 t -71.9 -47.81 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.268 -0.895 . . . . 1.12 109.338 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.99 -39.76 79.0 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.268 -0.895 . . . . 0.75 109.398 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.1 -33.6 74.83 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.226 -0.921 . . . . 0.86 109.36 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.77 -54.49 38.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.279 -0.888 . . . . 0.75 109.478 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -51.41 -41.91 61.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.23 -0.919 . . . . 2.14 109.44 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -70.94 -55.97 7.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.193 -0.942 . . . . 2.6 109.511 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.9 m -56.5 -33.26 65.84 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.08 -1.013 . . . . 1.55 109.427 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -72.78 -28.84 62.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.175 -0.953 . . . . 2.87 109.389 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -82.66 -24.13 33.88 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.306 -0.871 . . . . 2.51 109.45 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -71.53 -49.86 23.04 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.534 -1.427 . . . . 0.87 109.534 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.5 m -60.36 -33.27 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.264 -1.139 . . . . 0.92 109.421 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.43 -53.84 53.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.31 -0.869 . . . . 0.77 109.517 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -67.23 -37.08 82.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.337 -0.852 . . . . 2.23 109.453 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.61 -43.31 93.81 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.207 -0.933 . . . . 0.96 109.482 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -53.75 -59.49 4.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.211 -0.93 . . . . 0.95 109.443 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.69 -27.5 64.06 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.69 -1.364 . . . . 0.94 109.69 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -70.65 -45.19 65.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.164 -1.198 . . . . 3.13 109.281 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.9 m -65.14 -23.41 67.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.216 -0.928 . . . . 1.69 109.082 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -63.72 -37.16 86.31 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.502 -0.749 . . . . 3.37 109.421 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -81.28 -20.37 41.02 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.21 -0.931 . . . . 3.03 109.57 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -57.26 -57.05 21.8 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.714 -1.354 . . . . 1.19 109.714 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.3 m -57.13 -30.71 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.191 -1.182 . . . . 2.05 109.602 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 12.0 tp -85.94 119.49 26.31 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.173 -0.955 . . . . 2.37 109.39 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -67.07 160.93 25.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.198 -0.939 . . . . 4.83 108.958 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.52 ' O ' ' N ' ' A' ' 42' ' ' SER . 5.3 t -145.82 89.27 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.404 -0.81 . . . . 1.92 108.958 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -48.63 -9.93 0.1 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 110.141 -1.184 . . . . 0.84 110.141 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 40' ' ' VAL . 5.5 t -80.63 -46.89 14.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.036 -1.273 . . . . 1.67 109.621 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? -85.71 83.71 7.78 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.152 -0.967 . . . . 3.35 109.536 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.555 HG22 ' N ' ' A' ' 45' ' ' LYS . 92.8 m -91.31 165.76 13.26 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.312 -0.868 . . . . 0.93 109.413 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.555 ' N ' HG22 ' A' ' 44' ' ' THR . 62.8 mttm -50.18 -56.57 10.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.313 -0.867 . . . . 2.83 109.5 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -50.28 -33.65 20.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.241 -0.912 . . . . 2.71 109.546 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.57 -38.74 86.66 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.422 -1.471 . . . . 0.61 109.422 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 74.8 t -65.66 -46.11 90.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -1.148 . . . . 1.27 109.372 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 69.1 t -55.94 -39.31 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.2 -0.938 . . . . 0.91 109.407 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 42.4 t60 -70.21 -27.35 64.41 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.214 -0.929 . . . . 1.33 109.433 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -67.92 -60.76 5.41 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.503 -1.439 . . . . 0.57 109.503 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.0 m -56.11 -30.22 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.36 -1.082 . . . . 0.58 109.329 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.23 -35.32 77.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.207 -0.933 . . . . 0.65 109.463 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.2 m -75.7 -41.4 53.76 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.228 -0.92 . . . . 1.19 109.455 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 75.8 t -63.3 -22.32 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.219 -0.926 . . . . 0.63 109.506 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.02 -24.22 61.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.159 -0.963 . . . . 0.62 109.523 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -77.21 -40.5 44.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.158 -0.964 . . . . 2.61 109.382 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -70.17 -39.58 75.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.199 -0.938 . . . . 3.39 109.327 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.8 m -50.0 -27.38 5.37 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.296 -0.878 . . . . 1.29 109.486 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.437 ' O ' HG23 ' A' ' 64' ' ' THR . 66.8 mttm -72.44 -40.02 67.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.38 -0.825 . . . . 2.08 109.494 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -70.71 -22.64 62.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.278 -0.889 . . . . 2.19 109.558 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -79.79 -61.15 2.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.209 -0.932 . . . . 2.65 109.516 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.513 ' O ' ' N ' ' A' ' 67' ' ' GLY . 30.2 m -51.02 -32.44 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.19 -0.944 . . . . 0.82 109.542 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.437 HG23 ' O ' ' A' ' 60' ' ' LYS . 10.0 p -66.01 -47.32 74.85 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.178 -0.951 . . . . 1.48 109.472 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -66.32 -46.36 77.14 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.155 -0.966 . . . . 2.37 109.551 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 51.2 t -75.89 -28.02 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.176 -0.952 . . . . 1.5 109.465 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 63' ' ' VAL . . . -49.11 -36.54 21.55 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.58 -1.408 . . . . 0.77 109.58 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.93 -16.16 77.57 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.52 -1.432 . . . . 1.01 109.52 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.77 -48.4 11.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.206 -1.173 . . . . 1.09 109.579 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.9 m -58.59 -35.58 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.207 -0.933 . . . . 1.46 109.546 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 70.2 t -65.5 -45.16 93.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.166 -0.959 . . . . 1.02 109.165 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.1 p -66.42 -39.51 89.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.283 -0.886 . . . . 1.58 109.325 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -61.02 -54.36 37.45 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.49 -1.444 . . . . 0.95 109.49 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 79.8 t -51.4 -38.41 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.278 -1.13 . . . . 0.84 109.343 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 17.4 m -59.3 -41.18 88.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.276 -0.89 . . . . 1.7 109.303 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.34 -41.04 96.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.204 -0.935 . . . . 0.99 109.343 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 43.2 t -68.43 -31.97 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.219 -0.926 . . . . 1.02 109.351 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.66 -50.54 73.07 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.266 -0.896 . . . . 0.77 109.532 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -71.16 -17.41 62.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.254 -0.904 . . . . 2.53 109.324 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 55.0 tttm -81.8 -21.44 37.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.886 . . . . 2.9 109.145 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.3 m -81.18 -51.66 8.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.34 -0.85 . . . . 1.34 109.602 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.457 HG23 ' N ' ' A' ' 83' ' ' GLU . 33.5 m -52.68 -38.47 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.213 -0.929 . . . . 0.82 109.511 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.457 ' N ' HG23 ' A' ' 82' ' ' VAL . 96.7 mt-10 -63.16 -44.49 95.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.192 -0.943 . . . . 2.43 109.299 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -56.74 -25.43 51.64 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.389 -1.484 . . . . 0.9 109.389 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -57.49 -35.34 70.08 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.303 -1.116 . . . . 0.83 109.32 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -51.71 -43.71 54.04 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.417 -1.473 . . . . 0.93 109.417 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 38.3 t -59.9 -41.58 91.96 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.305 -1.115 . . . . 1.62 109.378 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 60.9 mt -61.11 -42.42 93.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.265 -0.897 . . . . 1.95 109.358 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.48 -41.11 65.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.218 -0.926 . . . . 1.33 109.321 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.03 -46.39 81.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.289 -0.882 . . . . 1.54 109.351 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -54.28 -42.56 70.15 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.162 -0.961 . . . . 1.93 109.39 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.9 m -77.56 -47.93 18.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.277 -0.889 . . . . 2.24 109.392 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -79.65 93.68 1.38 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.508 -1.437 . . . . 2.11 109.508 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -59.88 146.07 43.45 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.196 -1.179 . . . . 4.1 109.297 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.416 ' H ' HG22 ' A' ' 95' ' ' VAL . 1.6 m -52.18 101.52 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.139 -0.976 . . . . 3.97 109.23 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 48.9 tttp -46.73 163.31 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.239 -0.913 . . . . 5.01 109.598 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.5 102.45 2.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.168 -0.957 . . . . 6.31 109.565 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -95.14 113.87 25.61 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.171 -0.956 . . . . 5.96 109.999 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -175.72 -30.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.233 -0.917 . . . . 7.26 109.455 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 83.4 mt -112.14 158.32 19.78 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.633 -0.667 . . . . 7.54 109.744 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -130.21 -2.62 5.01 Favored Glycine 0 N--CA 1.497 2.753 0 N-CA-C 109.038 -1.625 . . . . 6.59 109.038 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 58.6 tttm 48.1 90.03 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.415 -1.05 . . . . 9.81 109.581 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -144.6 74.11 1.4 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.178 -0.951 . . . . 8.55 109.233 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.578 ' CD ' ' H ' ' A' ' 104' ' ' GLU . 1.0 OUTLIER -65.37 -42.05 93.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.038 -1.039 . . . . 10.62 109.503 -179.597 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 168.47 120.48 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 108.537 -0.912 . . . . 10.89 108.537 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -78.82 38.34 1.94 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.222 -1.551 . . . . 10.73 109.222 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 51.67 55.78 15.79 Favored Pre-proline 0 C--N 1.304 -1.388 0 O-C-N 121.506 -0.997 . . . . 11.04 109.772 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.46 ' O ' ' O ' ' A' ' 109' ' ' GLN . 93.4 Cg_endo -79.03 59.65 7.47 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.794 2.329 . . . . 10.48 111.885 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.46 ' O ' ' O ' ' A' ' 108' ' ' PRO . 78.6 mt-30 -57.01 -109.53 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.02 -1.05 . . . . 12.0 109.691 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -171.13 -17.46 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.139 -0.976 . . . . 10.8 109.374 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -168.29 -177.07 39.17 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.674 -1.37 . . . . 10.52 109.674 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.765 ' H ' HD13 ' A' ' 112' ' ' ILE . 0.0 OUTLIER -78.23 -37.67 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.205 -1.174 . . . . 10.7 109.548 179.898 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.527 ' C ' ' H ' ' A' ' 115' ' ' ASP . 85.3 mt -69.0 157.59 36.48 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.343 -0.848 . . . . 11.26 109.358 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -54.43 -3.87 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.183 -0.948 . . . . 12.14 109.657 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.527 ' H ' ' C ' ' A' ' 113' ' ' LEU . 28.3 t70 60.42 34.96 20.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.291 -0.881 . . . . 10.21 109.664 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.619 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 25.5 ttm -132.5 37.81 0.4 Allowed Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.588 -0.695 . . . . 10.65 110.384 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 116' ' ' MET . 62.1 Cg_endo -71.2 -12.18 29.77 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 122.131 1.887 . . . . 9.07 111.013 178.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.413 ' O ' HG13 ' A' ' 118' ' ' VAL . 11.6 p -54.81 134.23 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.655 -0.653 . . . . 10.62 109.973 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -97.84 126.84 39.24 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.424 -0.797 . . . . 9.67 108.972 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -74.67 -11.59 22.15 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.707 1.605 . . . . 9.55 112.035 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 122' ' ' ASN . 40.5 p-10 -63.84 -36.92 85.51 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.287 -0.883 . . . . 10.1 110.023 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.526 ' N ' ' OD1' ' A' ' 121' ' ' ASP . 32.3 p30 -170.31 30.68 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.193 -0.942 . . . . 11.06 109.814 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 66.99 -52.52 0.47 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.384 -0.823 . . . . 11.51 109.699 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 122' ' ' ASN . . . -156.57 -139.7 0.08 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.205 -0.934 . . . . 11.92 109.157 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.455 ' O ' ' ND2' ' A' ' 122' ' ' ASN . 89.6 m-85 -53.41 -72.31 0.06 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.005 -1.06 . . . . 12.63 108.971 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -151.08 88.83 1.48 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.381 -0.825 . . . . 13.68 109.214 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' MET . . . . . 0.447 ' CB ' ' CD ' ' A' ' 128' ' ' PRO . 0.9 OUTLIER 52.67 -171.21 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.689 0 N-CA-C 107.847 -1.168 . . . . 15.18 107.847 179.571 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.447 ' CD ' ' CB ' ' A' ' 127' ' ' MET . 51.3 Cg_exo -53.69 161.4 4.46 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 121.662 1.575 . . . . 14.6 112.014 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.443 ' O ' ' C ' ' A' ' 130' ' ' GLU . 78.1 p -57.75 -42.36 83.77 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.294 -0.879 . . . . 14.8 110.598 -178.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 129' ' ' SER . 20.5 pt-20 35.41 -149.52 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.601 -0.687 . . . . 15.64 110.617 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -134.6 44.27 2.68 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.196 -0.94 . . . . 16.06 109.159 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.568 ' O ' ' N ' ' A' ' 134' ' ' GLN . . . 73.38 -56.24 1.98 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.216 -1.553 . . . . 15.06 109.216 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 8.5 t80 56.83 -77.99 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.634 -0.921 . . . . 17.32 109.25 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.568 ' N ' ' O ' ' A' ' 132' ' ' GLY . 8.9 pt20 -155.17 126.39 7.21 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.008 -1.057 . . . . 15.71 109.437 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -163.33 -17.92 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.751 -0.833 . . . . 16.16 108.751 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -132.37 124.03 27.93 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.674 0.75 . . . . 17.15 109.177 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.419 ' CB ' ' CD ' ' A' ' 138' ' ' PRO . 1.8 mm-40 -57.9 -62.87 4.61 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.361 -0.837 . . . . 15.79 110.581 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.419 ' CD ' ' CB ' ' A' ' 137' ' ' GLU . 20.6 Cg_endo -58.84 167.92 4.89 Favored 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 122.32 2.013 . . . . 16.07 112.066 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.405 ' OE1' ' N ' ' A' ' 139' ' ' GLU . 57.6 mp0 -55.92 -27.05 50.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.385 -0.822 . . . . 16.68 109.677 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.839 0 CA-C-O 117.818 -1.087 . . . . 17.61 109.354 179.988 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.411 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.21 -0.663 . . . . 5.5899999999999999 109.21 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.423 ' C ' ' N ' ' A' ' 4' ' ' PHE . 1.2 m-20 -61.27 105.64 0.52 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.017 -1.052 . . . . 2.7599999999999998 108.9 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 58.6 t -51.25 -14.57 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.428 -0.795 . . . . 1.3600000000000001 109.558 -178.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.423 ' N ' ' C ' ' A' ' 2' ' ' ASP . 90.3 m-85 -77.64 -47.54 19.02 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.203 -0.936 . . . . 2.77 109.391 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 15.6 mmt -51.64 -49.54 62.06 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.252 -0.905 . . . . 1.8899999999999999 109.228 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -53.07 -57.17 11.33 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.323 -0.86 . . . . 2.7400000000000002 109.503 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -53.22 -31.16 41.15 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.529 -1.429 . . . . 0.85999999999999999 109.529 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.0 tp -74.65 -51.46 14.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.22 -1.165 . . . . 2.04 109.474 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.8 t -63.57 -22.08 66.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.249 -0.907 . . . . 1.48 109.51 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -75.18 -40.08 59.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.212 -0.93 . . . . 3.1200000000000001 109.448 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.72 -46.16 76.4 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.188 -0.945 . . . . 0.87 109.462 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -54.67 -32.49 59.32 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.187 -0.946 . . . . 3.02 109.482 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -65.56 -32.94 74.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.269 -0.894 . . . . 2.4900000000000002 109.451 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -79.11 -43.34 10.86 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.525 -1.43 . . . . 0.81000000000000005 109.525 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.1 t -57.79 -38.66 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.348 -1.09 . . . . 1.48 109.419 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 74.6 t -71.9 -47.81 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.268 -0.895 . . . . 1.1200000000000001 109.338 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.99 -39.76 79.0 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.268 -0.895 . . . . 0.75 109.398 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.1 -33.6 74.83 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.226 -0.921 . . . . 0.85999999999999999 109.36 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.77 -54.49 38.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.279 -0.888 . . . . 0.75 109.478 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -51.41 -41.91 61.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.23 -0.919 . . . . 2.1400000000000001 109.44 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -70.94 -55.97 7.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.193 -0.942 . . . . 2.6000000000000001 109.511 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.9 m -56.5 -33.26 65.84 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.08 -1.013 . . . . 1.55 109.427 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -72.78 -28.84 62.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.175 -0.953 . . . . 2.8700000000000001 109.389 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -82.66 -24.13 33.88 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.306 -0.871 . . . . 2.5099999999999998 109.45 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -71.53 -49.86 23.04 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.534 -1.427 . . . . 0.87 109.534 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.5 m -60.36 -33.27 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.264 -1.139 . . . . 0.92000000000000004 109.421 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.43 -53.84 53.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.31 -0.869 . . . . 0.77000000000000002 109.517 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -67.23 -37.08 82.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.337 -0.852 . . . . 2.23 109.453 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.61 -43.31 93.81 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.207 -0.933 . . . . 0.95999999999999996 109.482 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -53.75 -59.49 4.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.211 -0.93 . . . . 0.94999999999999996 109.443 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.69 -27.5 64.06 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.69 -1.364 . . . . 0.93999999999999995 109.69 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -70.65 -45.19 65.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.164 -1.198 . . . . 3.1299999999999999 109.281 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.9 m -65.14 -23.41 67.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.216 -0.928 . . . . 1.6899999999999999 109.082 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -63.72 -37.16 86.31 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.502 -0.749 . . . . 3.3700000000000001 109.421 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -81.28 -20.37 41.02 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.21 -0.931 . . . . 3.0299999999999998 109.57 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -57.26 -57.05 21.8 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.714 -1.354 . . . . 1.1899999999999999 109.714 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.3 m -57.13 -30.71 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.191 -1.182 . . . . 2.0499999999999998 109.602 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 12.0 tp -85.94 119.49 26.31 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.173 -0.955 . . . . 2.3700000000000001 109.39 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -67.07 160.93 25.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.198 -0.939 . . . . 4.8300000000000001 108.958 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.52 ' O ' ' N ' ' A' ' 42' ' ' SER . 5.3 t -145.82 89.27 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.404 -0.81 . . . . 1.9199999999999999 108.958 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -48.63 -9.93 0.1 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 110.141 -1.184 . . . . 0.83999999999999997 110.141 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 40' ' ' VAL . 5.5 t -80.63 -46.89 14.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.036 -1.273 . . . . 1.6699999999999999 109.621 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? -85.71 83.71 7.78 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.152 -0.967 . . . . 3.3500000000000001 109.536 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.555 HG22 ' N ' ' A' ' 45' ' ' LYS . 92.8 m -91.31 165.76 13.26 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.312 -0.868 . . . . 0.93000000000000005 109.413 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.555 ' N ' HG22 ' A' ' 44' ' ' THR . 62.8 mttm -50.18 -56.57 10.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.313 -0.867 . . . . 2.8300000000000001 109.5 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -50.28 -33.65 20.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.241 -0.912 . . . . 2.71 109.546 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.57 -38.74 86.66 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.422 -1.471 . . . . 0.60999999999999999 109.422 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 74.8 t -65.66 -46.11 90.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -1.148 . . . . 1.27 109.372 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 69.1 t -55.94 -39.31 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.2 -0.938 . . . . 0.91000000000000003 109.407 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 42.4 t60 -70.21 -27.35 64.41 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.214 -0.929 . . . . 1.3300000000000001 109.433 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -67.92 -60.76 5.41 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.503 -1.439 . . . . 0.56999999999999995 109.503 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.0 m -56.11 -30.22 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.36 -1.082 . . . . 0.57999999999999996 109.329 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.23 -35.32 77.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.207 -0.933 . . . . 0.65000000000000002 109.463 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.2 m -75.7 -41.4 53.76 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.228 -0.92 . . . . 1.1899999999999999 109.455 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 75.8 t -63.3 -22.32 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.219 -0.926 . . . . 0.63 109.506 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.02 -24.22 61.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.159 -0.963 . . . . 0.62 109.523 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -77.21 -40.5 44.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.158 -0.964 . . . . 2.6099999999999999 109.382 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -70.17 -39.58 75.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.199 -0.938 . . . . 3.3900000000000001 109.327 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.8 m -50.0 -27.38 5.37 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.296 -0.878 . . . . 1.29 109.486 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.437 ' O ' HG23 ' A' ' 64' ' ' THR . 66.8 mttm -72.44 -40.02 67.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.38 -0.825 . . . . 2.0800000000000001 109.494 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -70.71 -22.64 62.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.278 -0.889 . . . . 2.1899999999999999 109.558 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -79.79 -61.15 2.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.209 -0.932 . . . . 2.6499999999999999 109.516 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.513 ' O ' ' N ' ' A' ' 67' ' ' GLY . 30.2 m -51.02 -32.44 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.19 -0.944 . . . . 0.81999999999999995 109.542 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.437 HG23 ' O ' ' A' ' 60' ' ' LYS . 10.0 p -66.01 -47.32 74.85 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.178 -0.951 . . . . 1.48 109.472 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -66.32 -46.36 77.14 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.155 -0.966 . . . . 2.3700000000000001 109.551 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 51.2 t -75.89 -28.02 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.176 -0.952 . . . . 1.5 109.465 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 63' ' ' VAL . . . -49.11 -36.54 21.55 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.58 -1.408 . . . . 0.77000000000000002 109.58 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.93 -16.16 77.57 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.52 -1.432 . . . . 1.01 109.52 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.77 -48.4 11.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.206 -1.173 . . . . 1.0900000000000001 109.579 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.9 m -58.59 -35.58 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.207 -0.933 . . . . 1.46 109.546 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 70.2 t -65.5 -45.16 93.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.166 -0.959 . . . . 1.02 109.165 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.1 p -66.42 -39.51 89.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.283 -0.886 . . . . 1.5800000000000001 109.325 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -61.02 -54.36 37.45 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.49 -1.444 . . . . 0.94999999999999996 109.49 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 79.8 t -51.4 -38.41 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.278 -1.13 . . . . 0.83999999999999997 109.343 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 17.4 m -59.3 -41.18 88.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.276 -0.89 . . . . 1.7 109.303 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.34 -41.04 96.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.204 -0.935 . . . . 0.98999999999999999 109.343 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 43.2 t -68.43 -31.97 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.219 -0.926 . . . . 1.02 109.351 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.66 -50.54 73.07 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.266 -0.896 . . . . 0.77000000000000002 109.532 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -71.16 -17.41 62.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.254 -0.904 . . . . 2.5299999999999998 109.324 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 55.0 tttm -81.8 -21.44 37.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.886 . . . . 2.8999999999999999 109.145 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.3 m -81.18 -51.66 8.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.34 -0.85 . . . . 1.3400000000000001 109.602 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.457 HG23 ' N ' ' A' ' 83' ' ' GLU . 33.5 m -52.68 -38.47 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.213 -0.929 . . . . 0.81999999999999995 109.511 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.457 ' N ' HG23 ' A' ' 82' ' ' VAL . 96.7 mt-10 -63.16 -44.49 95.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.192 -0.943 . . . . 2.4300000000000002 109.299 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -56.74 -25.43 51.64 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.389 -1.484 . . . . 0.90000000000000002 109.389 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -57.49 -35.34 70.08 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.303 -1.116 . . . . 0.82999999999999996 109.32 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -51.71 -43.71 54.04 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.417 -1.473 . . . . 0.93000000000000005 109.417 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 38.3 t -59.9 -41.58 91.96 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.305 -1.115 . . . . 1.6200000000000001 109.378 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 60.9 mt -61.11 -42.42 93.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.265 -0.897 . . . . 1.95 109.358 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.48 -41.11 65.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.218 -0.926 . . . . 1.3300000000000001 109.321 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.03 -46.39 81.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.289 -0.882 . . . . 1.54 109.351 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -54.28 -42.56 70.15 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.162 -0.961 . . . . 1.9299999999999999 109.39 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.9 m -77.56 -47.93 18.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.277 -0.889 . . . . 2.2400000000000002 109.392 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -79.65 93.68 1.38 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.508 -1.437 . . . . 2.1099999999999999 109.508 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -59.88 146.07 43.45 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.196 -1.179 . . . . 4.0999999999999996 109.297 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.416 ' H ' HG22 ' A' ' 95' ' ' VAL . 1.6 m -52.18 101.52 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.139 -0.976 . . . . 3.9700000000000002 109.23 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 48.9 tttp -46.73 163.31 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.239 -0.913 . . . . 5.0099999999999998 109.598 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.5 102.45 2.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.168 -0.957 . . . . 6.3099999999999996 109.565 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -95.14 113.87 25.61 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.171 -0.956 . . . . 5.96 109.999 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -175.72 -30.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.233 -0.917 . . . . 7.2599999999999998 109.455 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 83.4 mt -112.14 158.32 19.78 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.633 -0.667 . . . . 7.54 109.744 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -130.21 -2.62 5.01 Favored Glycine 0 N--CA 1.497 2.753 0 N-CA-C 109.038 -1.625 . . . . 6.5899999999999999 109.038 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 58.6 tttm 48.1 90.03 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.415 -1.05 . . . . 9.8100000000000005 109.581 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -144.6 74.11 1.4 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.178 -0.951 . . . . 8.5500000000000007 109.233 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.578 ' H ' ' CD ' ' A' ' 104' ' ' GLU . 1.0 OUTLIER -65.37 -42.05 93.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.038 -1.039 . . . . 10.619999999999999 109.503 -179.597 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 168.47 120.48 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 108.537 -0.912 . . . . 10.890000000000001 108.537 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -78.82 38.34 1.94 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.222 -1.551 . . . . 10.73 109.222 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 51.67 55.78 15.79 Favored Pre-proline 0 C--N 1.304 -1.388 0 O-C-N 121.506 -0.997 . . . . 11.039999999999999 109.772 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.46 ' O ' ' O ' ' A' ' 109' ' ' GLN . 93.4 Cg_endo -79.03 59.65 7.47 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.794 2.329 . . . . 10.48 111.885 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.46 ' O ' ' O ' ' A' ' 108' ' ' PRO . 78.6 mt-30 -57.01 -109.53 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.02 -1.05 . . . . 12.0 109.691 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -171.13 -17.46 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.139 -0.976 . . . . 10.800000000000001 109.374 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -168.29 -177.07 39.17 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.674 -1.37 . . . . 10.52 109.674 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.765 ' H ' HD13 ' A' ' 112' ' ' ILE . 0.0 OUTLIER -78.23 -37.67 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.205 -1.174 . . . . 10.699999999999999 109.548 179.898 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.527 ' C ' ' H ' ' A' ' 115' ' ' ASP . 85.3 mt -69.0 157.59 36.48 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.343 -0.848 . . . . 11.26 109.358 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -54.43 -3.87 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.183 -0.948 . . . . 12.140000000000001 109.657 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.527 ' H ' ' C ' ' A' ' 113' ' ' LEU . 28.3 t70 60.42 34.96 20.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.291 -0.881 . . . . 10.210000000000001 109.664 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.619 ' N ' ' CD ' ' A' ' 117' ' ' PRO . 25.5 ttm -132.5 37.81 0.4 Allowed Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.588 -0.695 . . . . 10.65 110.384 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 116' ' ' MET . 62.1 Cg_endo -71.2 -12.18 29.77 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 122.131 1.887 . . . . 9.0700000000000003 111.013 178.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.413 ' O ' HG13 ' A' ' 118' ' ' VAL . 11.6 p -54.81 134.23 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.655 -0.653 . . . . 10.619999999999999 109.973 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -97.84 126.84 39.24 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.424 -0.797 . . . . 9.6699999999999999 108.972 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -74.67 -11.59 22.15 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.707 1.605 . . . . 9.5500000000000007 112.035 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 122' ' ' ASN . 40.5 p-10 -63.84 -36.92 85.51 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.287 -0.883 . . . . 10.1 110.023 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.587 HD22 ' N ' ' A' ' 122' ' ' ASN . 0.0 OUTLIER -170.31 30.68 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.193 -0.942 . . . . 11.06 109.814 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 66.99 -52.52 0.47 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.384 -0.823 . . . . 11.51 109.699 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.511 ' O ' ' ND2' ' A' ' 122' ' ' ASN . . . -156.57 -139.7 0.08 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.205 -0.934 . . . . 11.92 109.157 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -53.41 -72.31 0.06 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.005 -1.06 . . . . 12.630000000000001 108.971 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -151.08 88.83 1.48 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.381 -0.825 . . . . 13.68 109.214 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . 0.447 ' CB ' ' CD ' ' A' ' 128' ' ' PRO . 0.9 OUTLIER 52.67 -171.21 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.689 0 N-CA-C 107.847 -1.168 . . . . 15.18 107.847 179.571 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.447 ' CD ' ' CB ' ' A' ' 127' ' ' MET . 51.3 Cg_exo -53.69 161.4 4.46 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 121.662 1.575 . . . . 14.6 112.014 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.443 ' O ' ' C ' ' A' ' 130' ' ' GLU . 78.1 p -57.75 -42.36 83.77 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.294 -0.879 . . . . 14.800000000000001 110.598 -178.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 129' ' ' SER . 20.5 pt-20 35.41 -149.52 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.601 -0.687 . . . . 15.640000000000001 110.617 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -134.6 44.27 2.68 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.196 -0.94 . . . . 16.059999999999999 109.159 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.568 ' O ' ' N ' ' A' ' 134' ' ' GLN . . . 73.38 -56.24 1.98 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.216 -1.553 . . . . 15.06 109.216 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 8.5 t80 56.83 -77.99 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.634 -0.921 . . . . 17.32 109.25 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.568 ' N ' ' O ' ' A' ' 132' ' ' GLY . 8.9 pt20 -155.17 126.39 7.21 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.008 -1.057 . . . . 15.710000000000001 109.437 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -163.33 -17.92 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.751 -0.833 . . . . 16.16 108.751 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -132.37 124.03 27.93 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.674 0.75 . . . . 17.149999999999999 109.177 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.419 ' CB ' ' CD ' ' A' ' 138' ' ' PRO . 1.8 mm-40 -57.9 -62.87 4.61 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.361 -0.837 . . . . 15.789999999999999 110.581 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.419 ' CD ' ' CB ' ' A' ' 137' ' ' GLU . 20.6 Cg_endo -58.84 167.92 4.89 Favored 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 122.32 2.013 . . . . 16.07 112.066 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.405 ' OE1' ' N ' ' A' ' 139' ' ' GLU . 57.6 mp0 -55.92 -27.05 50.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.385 -0.822 . . . . 16.68 109.677 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.839 0 CA-C-O 117.818 -1.087 . . . . 17.609999999999999 109.354 179.988 . . . . . . . . 0 0 . 1 stop_ save_